FDA balances speed and safety in drug approvals

Reading

Read this text and listen to it at the same time. If you don’t know a word click it to see explanation, hear pronunciation or add it to vocabulary.

A new plan wants to make drug reviews faster at the FDA. This plan makes many people worried about important safety decisions.

Faster approvals are making FDA staff feel very stressed and confused. Many leaders have left because of worries about the plan's rules.

FDA scientists usually review drugs carefully for safety and effects. Now, drug approvals seem tied to White House price deals.

Key FDA officials have questioned who can legally approve these drugs. Some leaders have refused to sign off due to legal concerns.

The White House uses this plan to get lower drug prices. Companies also pushed for much faster review times than usual.

Answer the questions to the text. Speak or write, you choose. AI will assess your answers.

What does the new plan aim to do at the FDA?

The new plan wants to make drug reviews faster at the FDA.

Why are FDA staff feeling stressed?

Faster approvals are making FDA staff feel very stressed and confused.

What are some leaders worried about?

Some leaders are worried about the plan's rules and legal concerns.

Look at the article image and describe what you see on it. You may either speak or write your answer there.

Discuss this article with your AI tutor to practice. Your tutor will help you with vocabulary and grammar.

Read a new article every day and
discuss it with AI at lingolette.com